Ann DiBiase

Sr. Director, Global/US Commercial Training & Development at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Ann DiBiase's Colleagues at Alnylam Pharmaceuticals
Joshua Friedman

Senior Director, Clinical Research

Contact Joshua Friedman

Aaron Conant

Director Of Engineering

Contact Aaron Conant

Paul Nioi

Senior Director, Research

Contact Paul Nioi

Michelle Brooks

Associate Director, Clinical Data Management

Contact Michelle Brooks

William MD

Associate Director, Patient Safety and Risk Management

Contact William MD

Robin McDougall

Associate Director, DMPK, Translational PKPD Modeling

Contact Robin McDougall

View All Ann DiBiase's Colleagues
Ann DiBiase's Contact Details
HQ
(617) 551-8200
Location
Company
Alnylam Pharmaceuticals
Ann DiBiase's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Ann DiBiase
Ann DiBiase currently works for Alnylam Pharmaceuticals.
Ann DiBiase's role at Alnylam Pharmaceuticals is Sr. Director, Global/US Commercial Training & Development.
Ann DiBiase's email address is ***@alnylam.com. To view Ann DiBiase's full email address, please signup to ConnectPlex.
Ann DiBiase works in the SaaS industry.
Ann DiBiase's colleagues at Alnylam Pharmaceuticals are Joshua Friedman, Aaron Conant, Jennifer Valentino, Paul Nioi, Michelle Brooks, William MD, Robin McDougall and others.
Ann DiBiase's phone number is ["+14014133543"]
See more information about Ann DiBiase